ReviewMedical sciences (Basel, Switzerland)2026
Epigenetic Viral Mimicry in Neuroinflammation: Retrotransposons, cGAS-STING and Microglial Hysteresis.
Review in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endogenous retroviruses (ERVs), LINE-1 elements, and other endogenously active transposable-element families are now being studied for their role as a potential interface between epigenetic control and innate immunity. Here, we discuss how locus-specific failures in repressive complexes containing ATRX-DAXX-H3.3 and TRIM28-SETDB1-H3K9me3 may allow these elements to enter into unique molecular states that include double-stranded RNA, DNA/RNA hybrid molecules, RNA-protein complexes, reverse-transcription products, and RNA. Each of these states differs from the others in terms of its persistence, structural characteristics, and accessibility to sensors such as MDA5, RIG-I, cGAS-STING, and ZBP1, as well as host restriction pathways. We also emphasize that simply expressing a retroelement does not imply that it is competent to bind to a sensor and/or undergo productive retrotransposition. Rather, a distinction needs to be made between intermediate stages in the process of retrotransposition and productive retrotransposition itself. Therefore, the evidence needed to assign a specific sensor to a particular retroelement product must be presented. Furthermore, persistent stress caused by retroelement activity could converge with multiple cellular processes, such as p53-CDKN1A/p21-mediated cell-cycle arrest, PML-mediated nuclear organization, and lysosomal or metabolism-based changes leading to long-lived microglial states; however, demonstrating path dependence after removing the initiating perturbation would be required to demonstrate true hysteresis. Finally, downstream activation of complement pathways could have effects on synaptic function via separate CR3-dependent, trafficking-based, and contact-regulatory mechanisms. Overall, we recommend a locus-specific, structure-specific, and time-course-resolved approach for determining how the various states of endogenously active retroelements cross the genome-immunity boundary and contribute to neuroinflammatory dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.